OUR FIRM

Latest News

February 18, 2015

Guggenheim Partners Commences Operations in Japan

TOKYO – Guggenheim Partners, a global investment and advisory firm, announced today that its Japan-based subsidiary, Guggenheim Partners Japan, Ltd. (“GPJL”), has received its Type-1 and Type-2 Financial Instruments Business and Investment Advisory and Agency licenses from the Kanto Financial Bureau, the local regulatory authority, effective on February 16, 2015.

“We are very pleased that the Kanto Financial Bureau has granted us these licenses,” said Atsuhito Sakai, President and Representative Director of GPJL. “We look forward to extending Guggenheim Partners’ platform of innovative investment-management solutions to institutional investors and distributors in Japan, working with them to realize their objectives.” Guggenheim Partners initially established a representative office in Japan in 2014. GPJL’s office is located in Otemachi, Chiyoda-ku, Tokyo.

Guggenheim Partners Japan, Ltd. is a regulated entity licensed to conduct Type-1 and Type-2 Financial Instruments Business and Investment Advisory and Agency Business in Japan. The Type-1 Financial Instruments Business license covers GPJL’s intermediary business with liquid securities, and Type-2 covers business with illiquid securities, such as fund-related products.


About Guggenheim Partners

Guggenheim Partners is a global investment and advisory firm with more than $220 billion in assets under management. Across our three primary businesses of investment management, investment banking, and insurance services, we have a track record of delivering results through innovative solutions. With more than 2,500 professionals based in more than 25 offices around the world, our commitment is to advance the strategic interests of our clients and to deliver long-term results with excellence and integrity.


Contact in Japan

Guggenheim Partners Japan, Ltd.
Otemachi First Square, West Tower
1-5-1, Otemachi, Chiyoda-ku, Tokyo 100-0004
03-4577-7880



September 27, 2022

Vamil Divan Joins Guggenheim Securities as Biopharmaceutical Analyst

Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Vamil Divan has joined the firm as a Senior Research Analyst and Managing Director on the firm’s Healthcare research team.

Watch Video

September 19, 2022

Guggenheim Investments Wins WealthManagement.com 2022 Industry Award for Thought Leadership Advisor Education

Guggenheim Investments won the WealthManagement.com 2022 Industry Award for outstanding achievement in Thought Leadership Advisor Education at the magazine’s Sept. 8, 2022, annual award ceremony in New York.

Read More

August 18, 2022

Guggenheim Employees Volunteer for Annual Community Impact Campaign

Guggenheim Community Impact (GCI) drives volunteerism and maximizes the firm’s collective impact. GCI campaigns take place annually during the spring, summer, and fall seasons.

Watch Video